In answer to the growing need for innovation in breast cancer diagnostics, Doylestown Health has made the expansion of the accredited Women’s Diagnostic Center the newest priority of ONE VISION: The Campaign for Doylestown Health. Breast cancer is the leading form of cancer deaths in women, and the most common form of cancer both nationally and around the globe. Regular screenings are the most reliable way to find breast cancer early. Greater investment in technology, facilities, and staffing is critical to the early detection and prevention of breast cancer. Support for the Women’s Diagnostic Center will enable Doylestown Health to expand its existing facilities, allowing us to enhance the patient experience and treat more patients than ever before, more quickly and efficiently.